// App-Quantinova.ai

e15021 : Anatomic site of metastases can influence response to nivolumab in NSCLC patients.

Researchers

Presenter

  • Andrea Botticelli

Principal Investigators

  • Bruna Cerbelli

  • Paolo Sciattella

  • Massimiliano Salati

  • Ilaria Zizzari

  • Michela Roberto

  • Giulia Poti

  • Federica De Galitiis

  • Vincenzo Picone

  • Giulia D'Amati

  • Federica Mazzuca

  • Marianna Nuti

  • Paolo Marchetti

Medical Centers

  • Department of Clinical and Molecular Medicine, Sapienza University Sant' Andrea Hospital, Rome, Italy

  • Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Department of Experimental Medicine, Sapienza University Policlinico Umberto 1, Rome, Italy

  • Sant Andrea Hospital, Sapienza University of Rome, Rome, Italy

  • Sapienza University of Rome - Ospedale Sant'Andrea, Rome, Italy

  • Medical Oncology, Istituto Dermopatico Dell'immacolata, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved